IYHvsBBHETF Comparison
iShares U.S. Healthcare ETF (IYH) and VanEck Biotech ETF (BBH) belong to the same industry segment: US Health Care. IYH's top 3 sector exposures are Healthcare, Non-Corporate and Finance. In contrast, BBH's top sector exposures are Healthcare. IYH is more expensive with a Total Expense Ratio (TER) of 0.37%, versus 0.35% for BBH. IYH is up 16.78% year-to-date (YTD) with +$387M in YTD flows. BBH performs better with 30.28% YTD performance, and +$14M in YTD flows. Run a side-by-side ETF comparison of IYH and BBH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
IYH vs BBH performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IYH BBH | +5.36%+2.59% | +11.17%+20.83% | +16.78%+30.28% | +23.97%+39.64% | +46.86%+68.09% | +40.28%+26.27% |
| Flows | IYH BBH | +$409M+$7M | +$749M+$22M | +$387M+$14M | +$853M+$16M | +$375M-$134M | +$602M-$134M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IYH BBH | +17.64%+28.43% | +16.47%+22.41% | +15.20%+20.57% | +15.52%+21.85% |
| Max drawdown | IYH BBH | -5.88%-6.32% | -10.72%-10.54% | -17.89%-22.78% | -17.89%-34.47% |
| Max drawdown duration | IYH BBH | 56d36d | 169d150d | 445d440d | 445d1525d |
IYH | BBH | |
Last sale 10/26/2026 at 1:30 PM | $75.40 | $247.30 |
| Previous close 10/23/2026 | $75.40 | $246.57 |
| Consolidated volume 10/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IYH | BBH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IYH | BBH | |
|---|---|---|
| Last price | $75.40 | $247.30 |
| 1D performance | -0.00% | +0.30% |
| AuM | $4.51 B | $501.96 M |
| E/R | 0.37% | 0.35% |
IYH | BBH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | iShares | VanEck |
| Benchmark | Russell 1000 Health Care RIC 22.5/45 Capped Gross Index | MVIS US Listed Biotech 25 Index |
| N° of holdings | 101 | 24 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 12, 2000 | December 20, 2011 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
